UDCHOLIC 600 SR: Sustained-Release Support for Liver & Gallbladder Health

 UDCHOLIC 600 SR, manufactured by Steris Healthcare, is a hepatoprotective and biliary therapy formulated with Ursodeoxycholic Acid 600 mg in a sustained-release (SR) formulation. This medication is prescribed for the management of various liver and gallbladder-related conditions, including cholestatic liver diseases, gallstone dissolution in patients unsuitable for surgery, and certain chronic liver conditions where bile flow is impaired. As a naturally occurring bile acid, Ursodeoxycholic Acid works to improve liver function markers, protect liver cells, and support healthier bile composition, making UDCHOLIC 600 SR a widely trusted option in the treatment of hepatobiliary disorders.

Why It's Important

The liver and biliary system play a central role in digestion, detoxification, and metabolic regulation, and when bile flow becomes impaired or bile composition becomes imbalanced, it can lead to conditions ranging from gallstones to progressive liver damage. Conditions like Primary Biliary Cholangitis (PBC) and other cholestatic disorders cause bile to accumulate within the liver, leading to inflammation, cellular injury, and, if untreated, potential progression toward fibrosis or cirrhosis. This is why a targeted therapy like UDCHOLIC 600 SR is clinically important — it directly addresses the underlying bile acid imbalance rather than simply managing symptoms. By altering the composition of bile to make it less toxic to liver cells and improving bile flow, Ursodeoxycholic Acid helps slow disease progression, improve liver enzyme levels, and in many patients, delay or reduce the need for more invasive interventions such as surgery or liver transplantation.

Key Benefits 

What Are the Benefits of This Combination?

• Helps dissolve certain types of cholesterol gallstones in patients who are not candidates for surgery
• Improves liver enzyme levels (ALT, AST, ALP) in patients with cholestatic liver disease
• Reduces the toxicity of bile acids, protecting liver cells from ongoing damage
• Slows disease progression in conditions like Primary Biliary Cholangitis (PBC)
• Supports improved bile flow and reduces bile stasis within the liver
• Sustained-release formulation allows for more convenient, less frequent dosing
• May improve overall quality of life by reducing fatigue and itching associated with cholestatic conditions

Side Effects

UDCHOLIC 600 SR is generally well-tolerated, but like all medications, it may cause side effects in some patients. Commonly reported effects include mild diarrhea, nausea, abdominal discomfort, and a metallic or unusual taste in the mouth. These effects are typically mild and often improve as the body adjusts to the medication, particularly if taken with food.

Serious Side Effects

Although uncommon, patients should seek immediate medical attention if they experience signs of a severe allergic reaction (skin rash, itching, swelling of the face or throat, difficulty breathing), signs of worsening liver function (yellowing of the skin or eyes, dark urine, severe right upper abdominal pain), or severe, persistent diarrhea leading to dehydration. Any unusual or worsening symptoms during treatment should be promptly evaluated by a physician.

Available Substitutes

Several Ursodeoxycholic Acid formulations are available in the Indian pharmaceutical market, differing in strength, release mechanism (immediate-release vs. sustained-release), and brand. Patients should not switch between different Ursodeoxycholic Acid brands or formulations without consulting their physician, as differences in release profile can affect dosing frequency and therapeutic consistency. For a Steris Healthcare-manufactured alternative or a different strength, patients and PCD franchise partners are encouraged to consult the company's product portfolio directly.

Dosage Guidelines 

Dosage must always be individualized by a physician based on the patient's body weight, the specific condition being treated, and liver function status. UDCHOLIC 600 SR is typically taken once daily, generally with a meal, to support absorption and minimize gastrointestinal discomfort. The sustained-release tablet should be swallowed whole and not crushed or chewed, as this could interfere with its controlled-release mechanism. Treatment duration varies significantly depending on the underlying condition — gallstone dissolution therapy, for instance, often requires several months of consistent use, and periodic monitoring is typically recommended to assess treatment response.

Precautions & Warnings

UDCHOLIC 600 SR should not be used in patients with acute inflammation of the gallbladder or bile ducts, complete bile duct obstruction, or known hypersensitivity to bile acids or any of its components. It should be used with caution in patients with advanced liver cirrhosis, as response to therapy may be limited in later disease stages. Liver function tests are typically monitored periodically during treatment to assess response and detect any adverse changes early. This medication should be used cautiously in pregnant or breastfeeding women, only under strict medical supervision. Patients should inform their physician of all other medications being taken, as certain drugs (such as cholestyramine or antacids containing aluminium) can reduce the absorption of Ursodeoxycholic Acid if taken too close together.

How to Use & Mechanism of Action

UDCHOLIC 600 SR should be taken orally, once daily with a meal, and swallowed whole with a glass of water without crushing or chewing the sustained-release tablet. Its effectiveness comes from Ursodeoxycholic Acid's unique action as a hydrophilic bile acid. Under normal conditions, bile contains a mix of bile acids, some of which can be toxic to liver cells when they accumulate in excess. Ursodeoxycholic Acid works by altering the overall composition of the bile acid pool, making it less cytotoxic and more protective of liver cell membranes. It also reduces the intestinal absorption of more harmful, naturally occurring bile acids, decreases cholesterol saturation in bile (which helps dissolve cholesterol-based gallstones), and exerts immunomodulatory and anti-inflammatory effects within the liver. Together, these actions help protect liver cells, improve bile flow, and support better overall hepatobiliary function.

Conclusion

UDCHOLIC 600 SR by Steris Healthcare offers a well-established, targeted approach to managing cholestatic liver conditions and select gallstone disorders through its active ingredient, Ursodeoxycholic Acid (600mg), in a convenient sustained-release format. By improving bile composition, protecting liver cells, and supporting healthier bile flow, it plays an important role in slowing disease progression and improving liver function markers in appropriate patients. As with any hepatobiliary therapy, treatment should be initiated and monitored under medical supervision, with regular liver function assessments to ensure safe and effective long-term use.